{
    "organizations": [],
    "uuid": "08c8cd63b1987f9af8da3d248d683c70f869b0cd",
    "author": "",
    "url": "https://www.reuters.com/article/brief-momenta-pharmaceuticals-announces/brief-momenta-pharmaceuticals-announces-fda-approval-and-launch-of-glatopa-idUSASB0C5C5",
    "ord_in_thread": 0,
    "title": "BRIEF-Momenta Pharmaceuticals Announces FDA Approval And Launch Of Glatopa",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Momenta Pharmaceuticals Inc:\n* MOMENTA PHARMACEUTICALS ANNOUNCES FDA APPROVAL AND LAUNCH OF GLATOPA® (GLATIRAMER ACETATE INJECTION) 40 MG/ML\n* MOMENTA PHARMACEUTICALS- U.S. FDA HAS APPROVED SANDOZ‘S ABBREVIATED NEW DRUG APPLICATION FOR GLATOPA (GLATIRAMER ACETATE INJECTION) 40 MG/ML​\n* MOMENTA PHARMACEUTICALS - SANDOZ INITIATED LAUNCH OF THE PRODUCT IN U.S.\n* MOMENTA PHARMACEUTICALS - GLATOPA WAS DEVELOPED UNDER A COLLABORATION AGREEMENT BETWEEN MOMENTA AND SANDOZ AND IS PRODUCED IN THE US Source text for Eikon: Further company coverage: (Bengaluru Newsroom)\n ",
    "published": "2018-02-13T08:22:00.000+02:00",
    "crawled": "2018-02-13T08:33:06.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "momentum",
        "pharmaceutical",
        "inc",
        "momentum",
        "pharmaceutical",
        "announces",
        "fda",
        "approval",
        "launch",
        "glatiramer",
        "acetate",
        "injection",
        "momentum",
        "fda",
        "approved",
        "sandoz",
        "abbreviated",
        "new",
        "drug",
        "application",
        "glatopa",
        "glatiramer",
        "acetate",
        "injection",
        "momentum",
        "pharmaceutical",
        "sandoz",
        "initiated",
        "launch",
        "product",
        "momentum",
        "pharmaceutical",
        "glatopa",
        "developed",
        "collaboration",
        "agreement",
        "momentum",
        "sandoz",
        "produced",
        "u",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "bengaluru",
        "newsroom"
    ]
}